Susquehanna International Group, LLP Ab Cellera Biologics Inc. Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 248,645 shares of ABCL stock, worth $847,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares
248,645
Previous 417,396 40.43%
Holding current value
$847,879
Previous $1.22 Million 54.66%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$2.2 - $3.53 $371,252 - $595,691
-168,751 Reduced 40.43%
248,645 $554,000
Q4 2024

Feb 14, 2025
BUY
$2.48 - $3.15 $454,663 - $577,495
183,332 Added 78.33%
417,396 $1.22 Million
Q3 2024

Nov 14, 2024
SELL
$2.39 - $3.49 $35,094 - $51,247
-14,684 Reduced 5.9%
234,064 $606,000
Q2 2024

Aug 15, 2024
BUY
$2.73 - $4.73 $72,863 - $126,243
26,690 Added 12.02%
248,748 $736,000
Q1 2024

May 07, 2024
SELL
$4.29 - $5.97 $488,776 - $680,185
-113,934 Reduced 33.91%
222,058 $1.01 Million
Q4 2023

Feb 14, 2024
BUY
$3.91 - $5.93 $374,448 - $567,898
95,767 Added 39.87%
335,992 $1.92 Million
Q3 2023

Nov 14, 2023
SELL
$4.6 - $7.95 $1.37 Million - $2.38 Million
-298,781 Reduced 55.43%
240,225 $1.11 Million
Q2 2023

Aug 11, 2023
BUY
$5.66 - $7.59 $2.18 Million - $2.93 Million
385,667 Added 251.51%
539,006 $3.48 Million
Q1 2023

May 16, 2023
SELL
$7.31 - $11.18 $93,348 - $142,768
-12,770 Reduced 7.69%
153,339 $1.16 Million
Q4 2022

Feb 14, 2023
BUY
$9.48 - $14.52 $1.01 Million - $1.54 Million
106,065 Added 176.65%
166,109 $1.68 Million
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $552,404 - $821,401
60,044 New
60,044 $594,000
Q1 2022

May 16, 2022
SELL
$7.46 - $14.14 $2.13 Million - $4.04 Million
-285,901 Reduced 68.99%
128,512 $1.25 Million
Q4 2021

Feb 14, 2022
SELL
$12.99 - $17.73 $259,371 - $354,014
-19,967 Reduced 4.6%
414,413 $5.93 Million
Q3 2021

Nov 15, 2021
BUY
$14.85 - $21.34 $2.99 Million - $4.3 Million
201,554 Added 86.57%
434,380 $8.71 Million
Q2 2021

Aug 11, 2021
BUY
$20.19 - $34.17 $3.28 Million - $5.56 Million
162,626 Added 231.66%
232,826 $5.12 Million
Q1 2021

May 17, 2021
BUY
$23.29 - $53.2 $1.14 Million - $2.61 Million
49,105 Added 232.78%
70,200 $2.38 Million
Q4 2020

Feb 16, 2021
BUY
$39.0 - $58.9 $822,705 - $1.24 Million
21,095 New
21,095 $849,000

Others Institutions Holding ABCL

# of Institutions
150
Shares Held
132M
Call Options Held
156K
Put Options Held
346K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $972M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email